Rothova A, van der Lelij A, Stilma J S, Wilson W R, Barbe R F
Department of Ophthalmo-immunology, Netherlands Ophthalmic Research Institute, Amsterdam.
Lancet. 1989 Jun 24;1(8652):1439-41. doi: 10.1016/s0140-6736(89)90136-0.
In a prospective study to determine the tolerance for and safety of ivermectin therapy for onchocerciasis in a hyperendemic area in Sierra Leone, 28 (32%) of 87 patients had adverse reactions that required treatment with acetylsalicylic acid and antihistamines, but none of the observed adverse reactions were considered life-threatening. A significant relation was found between the frequency and severity of side-effects and the degree of parasite infestation, as quantified by the skin-snip counts. Free administration of ivermectin to severely infected onchocerciasis patients is not recommended without some form of medical supervision.
在一项前瞻性研究中,为了确定在塞拉利昂的一个高度流行地区伊维菌素治疗盘尾丝虫病的耐受性和安全性,87名患者中有28名(32%)出现不良反应,需要使用乙酰水杨酸和抗组胺药进行治疗,但所有观察到的不良反应均不被认为危及生命。通过皮肤切片计数量化发现,副作用的频率和严重程度与寄生虫感染程度之间存在显著关系。不建议在没有某种形式医疗监督的情况下,对严重感染的盘尾丝虫病患者免费给予伊维菌素。